SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-030606
Filing Date
2018-05-16
Accepted
2018-05-16 17:22:24
Documents
2
Period of Report
2018-05-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2213
2 POA DOCUMENT poa.txt EX-24.3_789447 3922
  Complete submission text file 0001209191-18-030606.txt   7534
Mailing Address 675 W. KENDALL STREET CAMBRIDGE MA 02142
Business Address 675 W. KENDALL STREET CAMBRIDGE MA 02142 617-949-2680
Cue Biopharma, Inc. (Issuer) CIK: 0001645460 (see all company filings)

IRS No.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 675 W. KENDALL STREET CAMBRIDGE MA 02142
Business Address
Suri Anish (Reporting) CIK: 0001739130 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38327 | Film No.: 18840935